Tredje AP-fonden
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1650290
SE-111 91 STOCKHOLM, V7
Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,200,122
-$5,209,044 QoQ
Shares Held
37,206
-25.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#177
of 784 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $108,189,503 across 9 Biotechnology names. ALNY ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,079 | $29,979,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,459 | $29,535,069 | |
| 3 | RPRX |
Royalty Pharma plc
|
219,990 | $12,334,839 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
37,206 | $11,200,122 | |
| 5 | INCY |
Incyte Corp
|
67,814 | $7,687,395 | |
| 6 | ASND |
Ascendis Pharma A/S
|
20,448 | $5,453,890 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
27,000 | $5,056,560 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
60,944 | $3,487,215 |
All Filings in ALNY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,200,122 | 37,206 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $16,409,166 | 49,594 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,083,749 | 40,447 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,135,936 | 13,456 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,978,950 | 12,202 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,295,208 | 15,907 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,292,390 | 9,742 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,358,409 | 19,483 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,734,369 | 19,483 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,957,764 | 19,791 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,788,195 | 19,791 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,640,467 | 20,556 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,248,577 | 22,368 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,225,948 | 26,088 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,766,339 | 24,264 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,772,214 | 23,842 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||